RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 132 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $65 | -100.0% | 50,288 | -79.5% | 0.01% | -79.2% |
| Q2 2022 | $277,000 | +109.8% | 245,227 | +537.6% | 0.02% | +166.7% |
| Q1 2021 | $132,000 | +20.0% | 38,459 | -15.7% | 0.01% | -52.6% |
| Q3 2020 | $110,000 | +64.2% | 45,636 | +24.9% | 0.02% | +137.5% |
| Q2 2020 | $67,000 | 0.0% | 36,539 | +41.6% | 0.01% | +100.0% |
| Q2 2019 | $67,000 | +45.7% | 25,798 | +42.6% | 0.00% | +33.3% |
| Q1 2019 | $46,000 | -69.3% | 18,089 | -72.2% | 0.00% | -62.5% |
| Q4 2018 | $150,000 | -54.0% | 65,180 | -35.9% | 0.01% | -60.0% |
| Q3 2018 | $326,000 | – | 101,612 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |